Pfizer (PFE) Announces FDA Acceptance of Methylphenidate HCI ERCT NDA as ADHD Treatment
Tweet Send to a Friend
Pfizer (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
